Panaxia Labs Israel Stock Current Liabilities
| HROD Stock | 5,673 202.00 3.69% |
Panaxia Labs Israel fundamentals help investors to digest information that contributes to Panaxia Labs' financial success or failures. It also enables traders to predict the movement of Panaxia Stock. The fundamental analysis module provides a way to measure Panaxia Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Panaxia Labs stock.
Panaxia |
Panaxia Labs Israel Company Current Liabilities Analysis
Panaxia Labs' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Panaxia Labs Israel has a Current Liabilities of 0.0. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Panaxia Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Panaxia Labs' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Panaxia Labs could also be used in its relative valuation, which is a method of valuing Panaxia Labs by comparing valuation metrics of similar companies.Panaxia Labs is currently under evaluation in current liabilities category among its peers.
Panaxia Fundamentals
| EBITDA | (15.07 M) | |||
| Net Income | 2.73 M | |||
| Cash And Equivalents | 2.6 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 13.21 M | |||
| Current Ratio | 2.79 X | |||
| Book Value Per Share | (6.55) X | |||
| Cash Flow From Operations | (1.7 M) | |||
| Earnings Per Share | (0.26) X | |||
| Beta | 1.17 | |||
| Market Capitalization | 57.97 M | |||
| Total Asset | 18.08 M | |||
| Z Score | 2.4 | |||
| Net Asset | 18.08 M |
About Panaxia Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Panaxia Labs Israel's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panaxia Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panaxia Labs Israel based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Panaxia Stock
Panaxia Labs financial ratios help investors to determine whether Panaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Panaxia with respect to the benefits of owning Panaxia Labs security.